Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE publishes diabetes guidance

  • Comment
INHALED insulin is not recommended for the treatment of people with type 1 or type 2 diabetes mellitus, according to National Institute for Clinical Excellence guidance published yesterday.

INHALED insulin is not recommended for the treatment of people with type 1 or type 2 diabetes mellitus, according to National Institute for Clinical Excellence guidance published yesterday.

However, the treatment may be used for those who have both conditions but show evidence of poor gylcaemic control despite other therapeutic interventions such as diet and oral hypoglycaemic agents.

In addition, the guidance 'Inhaled insulin for the treatment of diabetes (type 1 and 2)', said the drug could be used to treat those who are unable to initiate or intensify preprandial subcutaneous insulin therapy because of a persistent fear of injections.

It recommends data should be collected as part of a coordinated study, which should include patient outcomes, adverse events and measurements of lung function.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.